Jim Prutow

Jim Prutow

Jim Prutow is a partner at global management consulting firm PRTM (www.prtm.com). He can be reached at jprutow@prtm.com.

Recent posts

The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets
Life science tool companies have traditionally operated in the “research use only” market—selling equipment and reagents to academic labs, research centers and biopharmaceutical R&D. By selling into the research-only market, these... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Webinar
Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways
Robust, sensitive, & easy-to-use cell-based, reporter gene assays to study signaling pathways
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!